Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 455

1.

A questionnaire-based, multicenter registry of resistant and pseudo-resistant arterial

Kulach A, Stachowiak P, Prasal M, Sawicka K, Kosmala W, Kosior D, Kasprzak JD, Skowerski M, Sobkowicz B, Sinkiewicz W, Płońska-Gościniak E, Stępień M, Mizia-Stec K.

Wiad Lek. 2019 Oct 31;72(10):1866-1871.

PMID:
31978136
2.

A coronary fistula in the apical part of the left ventricle as a rare cause of stenocardia.

Hamala P, Kasprzak JD, Peruga JZ, Szymczyk K, Wierzbowska-Drabik K.

Kardiol Pol. 2020 Jan 22. doi: 10.33963/KP.15151. [Epub ahead of print] No abstract available.

3.

Cognitive behavioral intervention improves quality of life and perceived illness acceptance in patients after cardiac electrotherapy devices implantation.

Sobczak-Kaleta MA, Qawoq HD, Krawczyk M, Wierzbowska-Drabik K, Kasprzak JD.

Psychiatr Pol. 2019 Oct 30;53(5):1037-1051. doi: 10.12740/PP/109217. Epub 2019 Oct 30. English, Polish.

4.

Characterization of Patients with Pulmonary Arterial Hypertension: Data from the Polish Registry of Pulmonary Hypertension (BNP-PL).

Kopeć G, Kurzyna M, Mroczek E, Chrzanowski Ł, Mularek-Kubzdela T, Skoczylas I, Kuśmierczyk B, Pruszczyk P, Błaszczak P, Lewicka E, Karasek D, Mizia-Stec K, Tomaszewski M, Jacheć W, Ptaszyńska-Kopczyńska K, Peregud-Pogorzelska M, Doboszyńska A, Pawlak A, Gąsior Z, Zabłocka W, Ryczek R, Widejko-Pietkiewicz K, Waligóra M, Darocha S, Furdal M, Ciurzyński M, Kasprzak JD, Grabka M, Kamiński K, Hoffman P, Podolec P, Torbicki A.

J Clin Med. 2020 Jan 8;9(1). pii: E173. doi: 10.3390/jcm9010173.

5.

Treatment of chronic thromboembolic pulmonary hypertension in a multidisciplinary team.

Siennicka A, Darocha S, Banaszkiewicz M, Kędzierski P, Dobosiewicz A, Błaszczak P, Peregud-Pogorzelska M, Kasprzak JD, Tomaszewski M, Mroczek E, Zięba B, Karasek D, Ptaszyńska-Kopczyńska K, Mizia-Stec K, Mularek-Kubzdela T, Doboszyńska A, Lewicka E, Ruchała M, Lewandowski M, Łukasik S, Chrzanowski Ł, Zieliński D, Torbicki A, Kurzyna M.

Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619891529. doi: 10.1177/1753466619891529.

6.

Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry.

Lainščak M, Milinković I, Polovina M, Crespo-Leiro MG, Lund LH, Anker SD, Laroche C, Ferrari R, Coats AJS, McDonagh T, Filippatos G, Maggioni AP, Piepoli MF, Rosano GMC, Ruschitzka F, Simić D, Ašanin M, Eicher JC, Yilmaz MB, Seferović PM; European Society of Cardiology Heart Failure Long-Term Registry Investigators Group.

Eur J Heart Fail. 2019 Dec 20. doi: 10.1002/ejhf.1645. [Epub ahead of print]

PMID:
31863522
7.

A combined structural and biochemical approach reveals translocation and stalling of UvrB on the DNA lesion as a mechanism of damage verification in bacterial nucleotide excision repair.

Jaciuk M, Swuec P, Gaur V, Kasprzak JM, Renault L, Dobrychłop M, Nirwal S, Bujnicki JM, Costa A, Nowotny M.

DNA Repair (Amst). 2020 Jan;85:102746. doi: 10.1016/j.dnarep.2019.102746. Epub 2019 Nov 6.

8.

Resistant hypertension: Renal denervation or pharmacovigilance? Insights from a renal denervation screening program.

Ojrzanowski M, Kasprzak JD, Peruga JZ, Kurpesa M, Jankowski Ł, Sahni S, Plewka M.

Adv Clin Exp Med. 2019 Nov;28(11):1525-1530. doi: 10.17219/acem/104550.

9.

Functional, Anatomical, and Prognostic Correlates of Coronary Flow Velocity Reserve During Stress Echocardiography.

Ciampi Q, Zagatina A, Cortigiani L, Gaibazzi N, Borguezan Daros C, Zhuravskaya N, Wierzbowska-Drabik K, Kasprzak JD, de Castro E Silva Pretto JL, D'Andrea A, Djordjevic-Dikic A, Monte I, Simova I, Boshchenko A, Citro R, Amor M, Merlo PM, Dodi C, Rigo F, Gligorova S, Dekleva M, Severino S, Lattanzi F, Scali MC, Vrublevsky A, Torres MAR, Salustri A, Rodrìguez-Zanella H, Costantino FM, Varga A, Bossone E, Colonna P, De Nes M, Paterni M, Carpeggiani C, Lowenstein J, Gregori D, Picano E; Stress Echo 2020 Study Group of the Italian Society of Echocardiography and Cardiovascular Imaging.

J Am Coll Cardiol. 2019 Nov 5;74(18):2278-2291. doi: 10.1016/j.jacc.2019.08.1046.

PMID:
31672185
10.

Appropriate Shocks and Mortality in Patients With Versus Without Diabetes With Prophylactic Implantable Cardioverter Defibrillators.

Junttila MJ, Pelli A, Kenttä TV, Friede T, Willems R, Bergau L, Malik M, Vandenberk B, Vos MA, Schmidt G, Merkely B, Lubinski A, Svetlosak M, Braunschweig F, Harden M, Zabel M, Huikuri HV, Sticherling C; EU-CERT-ICD Investigators.

Diabetes Care. 2020 Jan;43(1):196-200. doi: 10.2337/dc19-1014. Epub 2019 Oct 23.

PMID:
31645407
11.

Database of Pulmonary Hypertension in the Polish Population (BNP‑PL): design of the registry.

Kopeć G, Kurzyna M, Mroczek E, Chrzanowski Ł, Mularek-Kubzdela T, Skoczylas I, Kuśmierczyk B, Pruszczyk P, Błaszczak P, Lewicka E, Karasek D, Mizia-Stec K, Tomaszewski M, Jacheć W, Ptaszyńska-Kopczyńska K, Peregud-Pogorzelska M, Doboszyńska A, Pawlak A, Gąsior Z, Zabłocka W, Ryczek R, Widejko-Pietkiewicz K, Waligóra M, Darocha S, Furdal M, Ciurzyński M, Kasprzak JD, Grabka M, Kwiatkowska J, Kamiński K, Hoffman P, Podolec P, Torbicki A.

Kardiol Pol. 2019 Oct 25;77(10):972-974. doi: 10.33963/KP.14988. Epub 2019 Sep 25. No abstract available. Erratum in: Kardiol Pol. 2019 Dec 19;77(12):1230.

12.

Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project.

Zabel M, Schlögl S, Lubinski A, Svendsen JH, Bauer A, Arbelo E, Brusich S, Conen D, Cygankiewicz I, Dommasch M, Flevari P, Galuszka J, Hansen J, Hasenfuß G, Hatala R, Huikuri HV, Kenttä T, Kucejko T, Haarmann H, Harden M, Iovev S, Kääb S, Kaliska G, Katsimardos A, Kasprzak JD, Qavoq D, Lüthje L, Malik M, Novotný T, Pavlović N, Perge P, Röver C, Schmidt G, Shalganov T, Sritharan R, Svetlosak M, Sallo Z, Szavits-Nossan J, Traykov V, Vandenberk B, Velchev V, Vos MA, Willich SN, Friede T, Willems R, Merkely B, Sticherling C; EU-CERT-ICD Study Investigators.

J Electrocardiol. 2019 Nov - Dec;57S:S34-S39. doi: 10.1016/j.jelectrocard.2019.09.001. Epub 2019 Sep 4. Review.

PMID:
31526572
13.

Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study.

Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, Popescu BA, Prendergast B, Tornos P, Sadeghpour A, Oliver L, Vaskelyte JJ, Sow R, Axler O, Maggioni AP, Lancellotti P; EURO-ENDO Investigators.

Eur Heart J. 2019 Oct 14;40(39):3222-3232. doi: 10.1093/eurheartj/ehz620.

PMID:
31504413
14.

Prevalence of hepatitis C virus infection in patients hospitalised for ischemic heart disease versus controls - PRO-CARDIO-C study.

Piekarska A, Mamzer-Dachnowska A, Kasprzak JD, Peruga JZ, Kaszuba A, Berkan-Kawińska A.

Clin Exp Hepatol. 2019 May;5(2):118-122. doi: 10.5114/ceh.2019.84782. Epub 2019 Apr 30.

15.

Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study.

Bauer A, Klemm M, Rizas KD, Hamm W, von Stülpnagel L, Dommasch M, Steger A, Lubinski A, Flevari P, Harden M, Friede T, Kääb S, Merkely B, Sticherling C, Willems R, Huikuri H, Malik M, Schmidt G, Zabel M; EU-CERT-ICD investigators.

Lancet. 2019 Oct 12;394(10206):1344-1351. doi: 10.1016/S0140-6736(19)31996-8. Epub 2019 Sep 2.

PMID:
31488371
16.

Effects of Serelaxin in Patients with Acute Heart Failure.

Metra M, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Voors AA, Adams KF, Anker SD, Arias-Mendoza A, Avendaño P, Bacal F, Böhm M, Bortman G, Cleland JGF, Cohen-Solal A, Crespo-Leiro MG, Dorobantu M, Echeverría LE, Ferrari R, Goland S, Goncalvesová E, Goudev A, Køber L, Lema-Osores J, Levy PD, McDonald K, Manga P, Merkely B, Mueller C, Pieske B, Silva-Cardoso J, Špinar J, Squire I, Stępińska J, Van Mieghem W, von Lewinski D, Wikström G, Yilmaz MB, Hagner N, Holbro T, Hua TA, Sabarwal SV, Severin T, Szecsödy P, Gimpelewicz C; RELAX-AHF-2 Committees Investigators.

N Engl J Med. 2019 Aug 22;381(8):716-726. doi: 10.1056/NEJMoa1801291.

PMID:
31433919
17.

Atrial septal defect type II and upper limb malformation in 40-year-old male as a manifestation of Holt-Oram syndrome.

Szymczyk E, Wejner-Mik P, Lipiec P, Michalski B, Kasprzak JD.

Cardiol J. 2019;26(3):302-303. doi: 10.5603/CJ.2019.0062. No abstract available.

18.

Right ventricular lead induced ventricular arrhythmia-A rare complication of cardiac resynchronization therapy.

Miśkowiec D, Życiński P, Qawoq DH, Pagórek P, Zając P, Chudzik M, Wcisło T, Kasprzak JD.

Ann Noninvasive Electrocardiol. 2019 Sep;24(5):e12666. doi: 10.1111/anec.12666. Epub 2019 Jun 26.

PMID:
31241241
19.

Percutaneous patent ductus arteriosus closure using intraprocedural mixed reality visualization of 3D computed tomography angiography data: first-in-man experience.

Kasprzak JD, Witowski J, Pawlowski J, Peruga JZ, Złahoda-Huzior A.

Eur Heart J Cardiovasc Imaging. 2019 Jul 1;20(7):839. doi: 10.1093/ehjci/jez008. No abstract available.

PMID:
31220228
20.

Quantitative assessment of the rotation and twist of the left ventricle during dobutamine stress echocardiography: a comparison of patients with and without significant coronary artery disease.

Mielczarek A, Kasprzak JD, Lipiec P, Miśkowiec D, Kurpesa M, Rechciński T, Szymczyk E, Wierzbowska-Drabik K.

Kardiol Pol. 2019 Aug 23;77(7-8):696-702. doi: 10.33963/KP.14870. Epub 2019 Jun 19.

Supplemental Content

Loading ...
Support Center